- Open Access
Follicular fluid levels of vascular endothelial growth factor and early corpus luteum function during assisted reproductive technology cycles
Journal of Experimental & Clinical Assisted Reproduction volume 2, Article number: 13 (2005)
The relation between vascular endothelial growth factor (VEGF) and early luteal function has rarely been proven in humans. The purpose of this study was to define the relation between follicular fluid concentrations of VEGF (FF VEGF) and early luteal function at the preimplantation stage during assisted reproductive technology (ART) cycles.
71 women were divided into two groups, based on reproductive outcome: women who became pregnant after embryo transfer (ET) (n = 18, Group A) and non-pregnant women (n = 53, Group B). Serum progesterone (Se P) and inhibin A on ET day, and FF VEGF levels were measured in all women. Data were expressed as mean ± standard deviation. Statistical analysis was performed using Excel Office 98 for Student's t-test, linear regression test and chi-square test. A p value of < 0.05 was considered statistically significant.
The groups were comparable for age, ovarian reserve, number and quality of the oocytes retrieved and of the embryos obtained and transferred. FF VEGF levels were increased (4235 ± 1433 vs 3432 ± 1231 pg/ml), while Se P and inhibin A levels were significantly reduced (83.1 ± 34.1 vs 112.0 ± 58.8 ng/ml and 397.4 ± 223 vs 533.5 ± 283 pg/ml, respectively) in the non-pregnant group and were negatively correlated with FF VEGF (r = -0.482, p < 0.05; r = -0.468, p < 0.05) only in pregnant women.
Much has to be learned about the regulation and role of VEGF during the early luteal phase. We advance the hypothesis that the existence of a negative correlation between FF VEGF/Se P and FF VEGF/inhibin A in pregnant women might indicate the existence of a normal VEGF-mediated paracrine response when Se P and inhibin A levels are decreased. Excess production of FF VEGF and the absence of a correlation between FF VEGF/Se P and FF VEGF/inhibin A in non-pregnant women may be a paracrine reaction to immature luteal vasculature, resulting in luteal dysfunction.
Fraser HM, Wulff C: Angiogenesis in the primate ovary. Reprod Fertil Dev. 2001, 13: 557-66. 10.1071/RD01055.
Dickson SE, Bicknell R, Fraser HM: Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor. J Endocrinol. 2001, 168: 409-16. 10.1677/joe.0.1680409.
Stouffer RL, Martinez-Chequer JC, Molskness TA, Xu F, Hazzard TM: Regulation and action of angiogenic factors in the primate ovary. Arch Med Res. 2001, 32: 567-75. 10.1016/S0188-4409(01)00323-X.
Wulff C, Dickson SE, Duncan WC, Fraser HM: Angiogenesis in the human corpus luteum: simulated early pregnancy by HCG treatment is associated with both angiogenesis and vessel stabilization. Hum Reprod. 2001, 16: 2515-24. 10.1093/humrep/16.12.2515.
Lee A, Christenson LK, Stouffer RL, Burry KA, Patton PE: Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization. Fertil Steril. 1997, 68: 305-11. 10.1016/S0015-0282(97)81520-8.
Staessen C, Van den Abbeel E, Janssenwillen C, Devroey P, Van Steirteghem AC: Controlled comparison of Earle's balanced salt solution with Menezo B2 medium for human in vitro fertilization performance. Human Reprod. 1994, 9: 1915-19.
Treetampinich C, O'Connor AE, MacLachlan V, Groome NP, de Kretser DM: Maternal serum inhibin A concentrations in early pregnancy after IVF and embryo transfer reflect the corpus luteum contribution and pregnancy outcome. Hum Reprod. 2000, 15: 2029-2032. 10.1093/humrep/15.9.2028.
Petraglia F, Garuti GC, Calza L, Roberts V, Giardino L, Genazzani AR, Vale W, Meunier H: Inhibin subunit in human placenta: localization and messenger ribonucleic acid concentration during pregnancy. Am J Obstet Gynecol. 1991, 165: 750-758.
Rombauts L, Verhoven G, Meuleman C, Koninckx PR, Poncelet E, Franchimont P: Dimeric inhibin A and alpha-subunit immunoreactive material in maternal serum during spontaneous and in-vitro fertilization pregnancies. J Clin Endocrinol Metab. 1996, 81: 985-989. 10.1210/jc.81.3.985.
Santoro N, Schneyer AL, Ibrahim J, Schmidt CL: Gonadotropin and inhibin concentrations in early pregnancy in women with and without corpora lutea. Obstet Gynecol. 1992, 79: 579-585.
Yohkaichiya T, Polson DW, Hughes EG, MacLachlan V, Robertson DM, Healy DL, de Kretser DM: Serum immunoreactive inhibin concentrations in early pregnancy after in vitro fertilization and embryo transfer: evidence for an ovarian source of inhibin and assessment of the inhibin measurements in predicting outcome of pregnancy. Fertil Steril. 1993, 5: 1081-1089.
Reynolds LP, Grazul-Bilska AT, Redmer DA: Angiogenesis in the corpus luteum. Endocrine. 2000, 12: 1-9. 10.1385/ENDO:12:1:1.
Fraser HM, Lunn SF: Angiogenesis and its control in the female reproductive system. Br Med Bull. 2000, 56: 787-97. 10.1258/0007142001903364.
Torry DS, Holt VJ, Keenan JA, Harris G, Caudle MR, Torry RJ: Vascular endothelial growth factor expression in cycling human endometrium. Fertil Steril. 1996, 66: 72-80.
Friedman CI, Danforth DR, Herbosa-Encarnación C, Arbogast L, Alak BM, Seifer DB: Follicular fluid vascular endothelial growth factor concentrations are elevated in women of advanced reproductive age undergoing ovulation induction. Fertil Steril. 1997, 68: 607-12. 10.1016/S0015-0282(97)00278-1.
Koga K, Osuga Y, Tsutsumi O, Momoeda M, Suenaga A, Kugu K, et al: Evidence for the presence of angiogenin in human follicular fluid and the up-regulation of its production by human chorionic gonadotropin and hypoxia. J Clin Endocrinol Metab. 2000, 85: 3352-55. 10.1210/jc.85.9.3352.
Battaglia C, Genazzani AD, Regnani G, Primavera MR, Petraglia F, Volpe A: Perifollicular Doppler flow and follicular fluid vascular endothelial growth factor concentrations in poor responders. Fertil Steril. 2000, 74: 809-12. 10.1016/S0015-0282(00)01517-X.
Neeman M, Abramovitch R, Schiffenbauer YS, Tempel C: Regulation of angiogenesis by hypoxic stress: from solid tumours to the ovarian follicle. Int J Exp Pathol. 1997, 78: 57-70. 10.1046/j.1365-2613.1997.d01-247.x.
Gosden RG, Byatt-Smith JG: Oxygen concentration gradient across the ovarian follicular epithelium: model, predictions and implications. Hum Reprod. 1986, 1: 65-68.
Van Blerkom J, Antczak M, Schrader R: The developmental potential of the human oocyte is related to the dissolved oxygen content of follicular fluid: association with vascular endothelial growth factor levels and perifollicular blood flow characteristics. Hum Reprod. 1997, 12: 1047-55. 10.1093/humrep/12.5.1047.
Stouffer RL: Corpus luteum formation and demise. Reproductive Endocrinology, Surgery, and Technology. Edited by: Adash EY, Rock JA, Rosenwaks Z. 1996, Lippincott – Raven Philadelphia, 1: 251-269.
The authors would like to acknowledge Mario Rossi, L.T., Rinaldo Spallanzani L.T., Maria Grazia Ziveri B.Sc., and medical student Manuela Calabrese for their precious assistance in data collection.
The author(s) declare that they have no competing interests.
FC have made substantial contributions to conception, design and interpretation of data. BF have made substantial contributions to interpretation of data. LB performed the statistical analysis. VC have made substantial contributions to acquisition of data.
MCS have made substantial contributions to acquisition of data. GP have been involved in revising the article critically.
Rights and permissions
Open Access This article is published under license to BioMed Central Ltd. This is an Open Access article is distributed under the terms of the Creative Commons Attribution License ( https://creativecommons.org/licenses/by/2.0 ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
About this article
Cite this article
Coppola, F., Ferrari, B., Barusi, L. et al. Follicular fluid levels of vascular endothelial growth factor and early corpus luteum function during assisted reproductive technology cycles . J Exp Clin Assist Reprod 2, 13 (2005). https://doi.org/10.1186/1743-1050-2-13